医薬 市場調査レポート

このリストでは医薬市場に関する調査レポートを新刊順に紹介しています。
例えば、薬学的薬物、生化学的薬物、バイオ薬物、抗感染性薬物といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。又、調剤薬、診断薬、公衆衛生用薬、治療を主目的としない薬物に関する調査レポートも紹介しています。

高悪性度神経膠腫 (腫瘍学) - 開発段階の治療薬　2021年

High-Grade Glioma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

High-Grade Glioma (Oncology) - Drugs in Development, 2021SummaryHigh-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape.The report provides comprehensive information on the therapeutics un…

このレポートの詳細ページはこちら

高トリグリセリド血症 (循環器) - 開発段階の治療薬　2021年

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021SummaryHypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Hypertriglyceridemia pipeline landscape.The report provides comprehensive information o…

このレポートの詳細ページはこちら

甲状腺乳頭がん (腫瘍学) - 開発段階の治療薬　2021年

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021SummaryPapillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Thyroid Cancer pipeline landscape.The report provides comprehensive information o…

このレポートの詳細ページはこちら

筋層非浸潤性膀胱がん (NMIBC) (表在性膀胱がん) (腫瘍学) - 開発段階の治療薬　2021年

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021SummaryNon Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of t…

このレポートの詳細ページはこちら

筋層浸潤性膀胱がん (MIBC) (腫瘍学) - 開発段階の治療薬　2021年

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021SummaryMuscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape.The repo…

このレポートの詳細ページはこちら

胸腺がん (腫瘍学) - 開発段階の治療薬　2021年

Thymic Carcinoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Thymic Carcinoma (Oncology) - Drugs in Development, 2021SummaryThymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape.The report provides comprehensive information on the therapeutics under…

このレポートの詳細ページはこちら

急性肺障害 (呼吸器) - 開発段階の治療薬　2021年

Acute Lung Injury (Respiratory) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Lung Injury (Respiratory) - Drugs in Development, 2021SummaryAcute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape.The report provides comprehensive information on the therapeut…

このレポートの詳細ページはこちら

急性心不全 (循環器) - 開発段階の治療薬　2021年

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021SummaryAcute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline landscape.The report provides comprehensive information on t…

このレポートの詳細ページはこちら

急性虚血性脳卒中 (中枢神経系) - 開発段階の治療薬　2021年

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021SummaryAcute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute Ischemic Stroke pipeline landscape.The report provides comprehe…

このレポートの詳細ページはこちら

急性感音性難聴 (耳鼻咽喉科疾患) - 開発段階の治療薬　2021年

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021SummaryAcute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Acute Sensorineural Hearing Loss pipeline…

このレポートの詳細ページはこちら

急性冠症候群 (循環器) - 開発段階の治療薬　2021年

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021SummaryAcute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome pipeline landscape.The report provides comprehensive info…

このレポートの詳細ページはこちら

肝臓がん (腫瘍学) - 開発段階の治療薬　2021年

Liver Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Liver Cancer (Oncology) - Drugs in Development, 2021SummaryLiver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…

このレポートの詳細ページはこちら

肝外胆管がん (腫瘍学) - 開発段階の治療薬　2021年

Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021SummaryExtrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Extrahepatic Bile Duct Cancer pipeline landscape.The report provides comprehensiv…

このレポートの詳細ページはこちら

冠動脈疾患 (CAD) （虚血性心疾患） (循環器) - 開発段階の治療薬　2021年

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021SummaryCoronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Coronary Artery Dis…

このレポートの詳細ページはこちら

外陰がん (腫瘍学) - 開発段階の治療薬　2021年

Vulvar Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Vulvar Cancer (Oncology) - Drugs in Development, 2021SummaryVulvar Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Vulvar Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under developm…

このレポートの詳細ページはこちら

化学療法誘発骨髄抑制 (腫瘍学) - 開発段階の治療薬　2021年

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021SummaryChemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 provides an overview of the Chemotherapy Induced Myelosuppression pipeline landscape.The repo…

このレポートの詳細ページはこちら

炎症性腸疾患 (胃腸) - 開発段階の治療薬　2021年

Inflammatory Bowel Disease (Gastrointestinal) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Inflammatory Bowel Disease (Gastrointestinal) - Drugs in Development, 2021SummaryInflammatory Bowel Disease (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Inflammatory Bowel Disease pipeline landscape.The report provides compr…

このレポートの詳細ページはこちら

胃食道（GE）接合部がん (腫瘍学) - 開発段階の治療薬　2021年

Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021SummaryGastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Gastroesophageal (GE) Junction Carcinomas pipeline landsc…

このレポートの詳細ページはこちら

移行上皮がん（尿路上皮細胞がん） (腫瘍学) - 開発段階の治療薬　2021年

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021SummaryTransitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of the Transitional Cell Cancer (Urothelial Cell…

このレポートの詳細ページはこちら

悪性神経膠腫 (腫瘍学) - 開発段階の治療薬　2021年

Malignant Glioma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Malignant Glioma (Oncology) - Drugs in Development, 2021SummaryMalignant Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Glioma pipeline landscape.The report provides comprehensive information on the therapeutics under…

このレポートの詳細ページはこちら